# NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Amgen Ltd
- Award value: £264,003,228
- Tender value: £264,003,000
- Award date: 3 March 2023
- Published: 24 March 2023
- Contract start: 1 April 2023
- Contract end: 28 February 2026
- Stage: awarded
- Procurement category: goods
- Notice ID: a6b9f437-01c6-49a7-a10f-e629b7cdf660-627683
- OCID: ocds-b5fd17-f074e643-f848-4b2d-aec8-e624b3fc10e0

## Description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England\. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East\. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London\. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England\. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months

## Related contract awards

- [NASSTAR T1510 WTE Teams Telephony](/contracts/ocds-b5fd17-1bdf9a7a-14ea-4c0c-be0c-39fd8574a761): NHS England
- [NHP Information Management Project Controls Platform](/contracts/ocds-b5fd17-4fcc30c7-0eb2-417b-a7da-de99843314bd): NHS England
- [SolarWinds Licensing and Support - 2026-29](/contracts/ocds-b5fd17-6db83b63-5b91-42b9-bb0d-13c34a9c513c): NHS England
- [CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab](/contracts/ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30): NHS England
- [NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024](/contracts/ocds-b5fd17-f8f31612-30fe-46cd-8155-9f4881ec58c8): NHS England
- [NHS Framework Colorectal Cancer Drugs \(See description below\)](/contracts/ocds-b5fd17-9a3056a9-6b7f-4b93-8ee8-f0125b6dd420): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/a6b9f437-01c6-49a7-a10f-e629b7cdf660-627683)